There is evidence that indicates EGFR, TrkB, and IL-1β are essential to maintaining a mesenchymal subpopulation associated with chemotherapeutic resistance in HNSCC [103,116,117]. This evidence concerns the gene NTRK2 and head and neck squamous cell carcinoma.